HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lien T Ngo Selected Research

Chimeric Antigen Receptors

2/2015Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lien T Ngo Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 11/2005
2Melanoma (Melanoma, Malignant)
05/2015 - 11/2005
1Breast Neoplasms (Breast Cancer)
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2019
1Liver Diseases (Liver Disease)
05/2015
1Fever (Fevers)
05/2015
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2015
1Lymphopenia (Lymphocytopenia)
05/2006
1Inflammation (Inflammations)
03/2006

Drug/Important Bio-Agent (IBA)

5T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 11/2008
3Neoplasm Antigens (Tumor Antigens)IBA
01/2022 - 11/2005
3AntigensIBA
01/2022 - 11/2008
2Proteins (Proteins, Gene)FDA Link
01/2019 - 11/2008
2Peptides (Polypeptides)IBA
03/2006 - 11/2005
1HLA-A Antigens (HLA-A)IBA
01/2022
1Mutant Proteins (Protein, Mutant)IBA
01/2019
1Interleukin-2 (IL2)IBA
05/2015
1Interleukin-12 (IL 12)IBA
05/2015
1Chimeric Antigen ReceptorsIBA
02/2015
1Interleukin-7 (Interleukin 7)IBA
05/2006
1EmulsionsIBA
03/2006
1HLA-A*02:01 antigenIBA
11/2005
1Biomarkers (Surrogate Marker)IBA
11/2005
1EpitopesIBA
11/2005
1VaccinesIBA
11/2005

Therapy/Procedure

7Immunotherapy
01/2022 - 11/2008
1Therapeutics
01/2022
1Drug Therapy (Chemotherapy)
02/2015